APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 6mg capsule bottle

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

rivastigmine hydrogen tartrate, Quantity: 9.6 mg

Disponibil de la:

Arrotex Pharmaceuticals Pty Ltd

INN (nume internaţional):

rivastigmine hydrogen tartrate

Forma farmaceutică:

Capsule

Compoziție:

Excipient Ingredients: Gelatin; iron oxide red; stearic acid; titanium dioxide; microcrystalline cellulose; maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Calea de administrare:

Oral

Unități în pachet:

56, 500, 100

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

Rezumat produs:

Visual Identification: Hard gelatine calsule with orange, opaque body and red opaque cap. Imprinted "APO R6" in black ink, white to off white fill.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2010-07-27